Nephrotoxicity of Vancomycin in Combination with Beta-lactam Agents: Ceftolozane-tazobactam vs. Piperacillin-tazobactam

Alosaimy, S., Lagnf, A. M., Hobbs, A., Mubarez, M., Kufel, W. D., Morrisette, T., Polisetty, R. S., Li, D., Veve, M. P., Simon, S. P., Truong, J., Finch, N., Venugopalan, V., Rico, M., Amaya, L., Yost, C., Cubillos, A., Chandler, E., Patch, M., Smith, I., … Rybak, M. J. (2022). Nephrotoxicity of Vancomycin in Combination with Beta-lactam Agents: Ceftolozane-tazobactam vs. Piperacillin-tazobactam. Clinical Infectious Diseases: An official publication of the Infectious Diseases Society of America. Advance online publication. https://doi.org/10.1093/cid/ciac670

Category